#obesity research

A Nature study in mice suggests low-protein diets can trigger gut microbe-driven signals that turn white fat toward a calorie-burning beige state, revealing a complex microbiome link in metabolism.

Researchers at the University of Oklahoma report that FGF21 reverses obesity in mice by acting through a hindbrain circuit linked to metabolism, pointing to a pathway distinct from appetite-suppressing GLP-1 drugs.

With one in eight American adults now taking GLP-1 medications like Ozempic and Wegovy, researchers at Georgia State University have uncovered why patients regain weight after stopping treatment — and a potential combination therapy that could solve the problem by targeting the brain's stress response system.